Center for Biologics Evaluation and Research (U.S.). (2008). Guidance for industry: Nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-derived Products. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2008.
MLA (9th ed.) CitationCenter for Biologics Evaluation and Research (U.S.). Guidance for Industry: Nucleic Acid Testing (NAT) to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-derived Products. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, 2008.